PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 21, 2025International Journal of Molecular Sciences41 citationsOpen Access

Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy

View Full Paper
AIAekkhaluck IntharuksaWAWarunya ArunotayanunMTMingkwan Na Takuathung

Key Points

  • Daidzein and genistein are phytoestrogens that may serve as alternatives to hormone replacement therapy.
  • Clinical trials indicate these compounds can reduce vasomotor symptoms, particularly in equol producers.
  • Studies show these isoflavones bind preferentially to estrogen receptors, affecting various bodily functions.
  • Their use may lower the risk of hormone-sensitive cancers, making them safer for some women.

Abstract

Menopause is characterized by a decline in estrogen levels, leading to symptoms such as vasomotor instability, osteoporosis, and increased cardiovascular and cognitive risk. Hormone replacement therapy (HRT) remains the gold standard for managing menopausal symptoms; however, concerns regarding its long-term safety, including elevated risks of cancer and cardiovascular events, have prompted interest in alternative therapies. Phytoestrogens, particularly the isoflavones daidzein and genistein, are plant-derived compounds structurally similar to 17β-estradiol (E2) and capable of binding estrogen receptors. Found abundantly in soybeans and red clover, these compounds exhibit selective estrogen receptor modulator (SERM)-like activity, favoring ERβ over ERα, which underlies their tissue-specific effects. In vitro, in silico, and in vivo studies demonstrate their ability to modulate estrogenic pathways, inhibit oxidative stress, and influence reproductive and neurological function. Clinical trials show that daidzein and genistein, especially in equol-producing individuals, can reduce vasomotor symptoms such as hot flashes and night sweats. While results across studies vary, consistent findings support their safety and modest efficacy, particularly for women unable or unwilling to use HRT. Pharmacokinetic studies reveal moderate bioavailability and interindividual variability due to gut microbiota metabolism. At dietary levels, these compounds are generally safe, although high-dose supplementation is discouraged in individuals with hormone-sensitive cancers. Emerging evidence suggests lifelong consumption of soy-based foods may reduce cancer risk. In conclusion, daidzein and genistein represent promising, well-tolerated natural alternatives to conventional HRT, offering symptom relief and additional health benefits. Further research is warranted to optimize dosing, improve clinical outcomes, and clarify long-term safety in diverse populations, particularly with genetic variations in isoflavone metabolism.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Intharuksa et al. (2025) studied this question.

synapsesocial.com/papers/689a060ee6551bb0af8cd330https://doi.org/10.3390/ijms26146973
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genistein and daidzein induce ferroptosis in MDA-MB-231 cells2024 · 10 citations
  2. 2Daidzein alleviates osteoporosis by promoting osteogenesis and angiogenesis coupling2023 · 23 citations
  3. 3Daidzein ameliorates experimental traumatic brain injury‐induced neurological symptoms by suppressing oxidative stress and apoptosis2024 · 6 citations
  4. 4Transcriptome analysis of Pueraria candollei var. mirifica for gene discovery in the biosyntheses of isoflavones and miroestrol2019 · 34 citations
  5. 5Phytoestrogen Interaction with Estrogen Receptors in Human Breast Cancer Cells*1978 · 604 citations